Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
226.00    -2.40 (-1.05%)
Bid:
226.00
Ask:
226.40
Spread: 0.40 (0.177%)
Market Cap: £2.21b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

17 Aug 2020 14:45

RNS Number : 3575W
Serco Group PLC
17 August 2020
 

17 August 2020

Serco Group plc

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ORDINARY SHARES OF 2p EACH IN THE COMPANY ('Ordinary Shares')

 

On 14 August 2020, Mark Irwin exercised nominal-cost options granted under the 2009 Serco Performance Share Plan and, on the same date, sold the resultant Ordinary Shares acquired.

 

A summary of the Ordinary Shares acquired and sold is set out below.

 

Name of PDMR

Grant date of award

Vest date of award

Number of Ordinary Shares acquired

Ordinary Shares sold

Mark Irwin, CEO, ASPAC

6 April 2017

6 April 2020

116,809

116,809

 

The price for the disposal of the Ordinary Shares was £1.3806 per Share.

 

This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.

 

The notification of dealing forms for these transactions can be found below.

 

Transaction notification

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mark Irwin

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, ASPAC

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc ('the Company')

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The exercise of nominal-cost options over Ordinary Shares granted on 6 April 2017 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.02

116,809

d)

 

Aggregated information

- Aggregated volume

116,809

- Price

£2,336.18

e)

 

Date of the transaction

 

14 August 2020

f)

 

Place of the transaction

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The sale of Ordinary Shares following the exercise of nominal-cost options over Ordinary Shares on 14 August 2020 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.3806

116,809

d)

 

Aggregated information

- Aggregated volume

116,809

- Price

£161,266.51

e)

 

Date of the transaction

 

14 August 2020

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBUORRBUWAAR
Date   Source Headline
5th Aug 202010:45 amRNSHolding(s) in Company
3rd Aug 202010:57 amRNSTotal Voting Rights
30th Jul 20202:21 pmRNSHolding(s) in Company
16th Jul 20203:53 pmRNSDirectorate Change - NED Changes
1st Jul 20202:40 pmRNSTotal Voting Rights
29th Jun 20202:01 pmRNSHolding(s) in Company
26th Jun 202012:55 pmRNSHolding(s) in Company
25th Jun 20203:42 pmRNSHolding(s) in Company
23rd Jun 20203:15 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:50 pmRNSHolding(s) in Company
22nd Jun 20202:31 pmRNSHolding(s) in Company
17th Jun 20204:11 pmRNSHolding(s) in Company
17th Jun 20207:00 amRNSClosed period trading update
1st Jun 202010:33 amRNSTotal Voting Rights
29th May 202012:09 pmRNSHolding(s) in Company
28th May 20202:30 pmRNSDirectorate Change
28th May 202010:01 amRNSHolding(s) in Company
22nd May 20203:58 pmRNSDirector Declaration
14th May 20203:30 pmRNSDirector/PDMR Shareholding
14th May 20201:18 pmRNSResult of AGM
7th May 202011:00 amRNSDirector/PDMR Shareholding
1st May 202010:21 amRNSTotal Voting Rights
29th Apr 202012:55 pmRNSAmendment: AGM 2020 - Change of Arrangements
29th Apr 202011:30 amRNSDirector/PDMR Shareholding
29th Apr 202011:00 amRNSAGM 2020 - Change of Arrangements
28th Apr 202012:13 pmRNSDisclosure of rights attached to equity shares
21st Apr 20203:23 pmRNSDirector/PDMR Shareholding
15th Apr 20204:22 pmRNSDirector/PDMR Shareholding
9th Apr 20201:32 pmRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSTrading update regarding Coronavirus
1st Apr 202011:30 amRNSIssue of shares to Employee Share Ownership Trust
1st Apr 202010:21 amRNSTotal Voting Rights
27th Mar 202012:19 pmRNSHolding(s) in Company
19th Mar 20203:00 pmRNSNotice of AGM
12th Mar 20203:32 pmRNSAnnual Financial Report
9th Mar 20207:00 amRNSFiona Stanley Hospital £370m extension signed
5th Mar 20209:46 amRNSHolding(s) in Company
2nd Mar 202010:16 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSDividend Declaration
26th Feb 20207:00 amRNSFinal Results
20th Feb 202010:24 amRNSGatwick Immigration Removal Centres £200m contract
7th Feb 202010:19 amRNSHolding(s) in Company
3rd Feb 202010:18 amRNSTotal Voting Rights
23rd Jan 20209:30 amRNSDirector Declaration
2nd Jan 202010:00 amRNSTotal Voting Rights
18th Dec 201912:02 pmRNSHolding(s) in Company
17th Dec 201911:49 amRNSHolding(s) in Company
12th Dec 20197:00 amRNSClosed Period trading update
9th Dec 20194:15 pmRNSHolding(s) in Company
2nd Dec 201910:56 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.